TrialCancer chemotherapy and pharmacology2013

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.

Sook Ryun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.